Women who use Evamist, an estrogen spray applied to the skin to treat symptoms of menopause, should not come in contact with children or pets because children and pets may experience adverse effects such as nipple swelling from unintentional exposure, according to a new Food and Drug Administration (FDA) consumer update.
Evamist contains the estrogen hormone estradiol. It is sprayed inside the forearm between the elbow and the wrist. The FDA is currently reviewing reports of adverse events in children and pets who were unintentionally exposed to Evamist, including reports of premature puberty, nipple swelling and breast development in girls and breast enlargement in boys. Pets exposed to Evamist may also show signs of nipple enlargement or vulvar swelling.
The FDA is recommending that women using Evamist to not let children come in contact with the area of the arm where the spray was applied nor to let pets lick or touch the area. If contact cannot be avoided, women should wear a garment that covers the arm where Evamist was sprayed. If a child comes in contact with the arm where Evamist was applied, immediately wash the child’s skin with soap and water. If a child exposed to Evamist begins exhibiting symptoms or becomes ill, contact a health care professional. If pets exposed to Evamist exhibit symptoms or become ill, contact a veterinarian.
It is unknown whether unintended exposure can occur with other topical estrogen products. Any adverse events with this or any other medication should be reported to the FDA MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch.